Prapela, founded in 2017, is a health and wellness company dedicated to improving newborn health through affordable, noninvasive stimulation therapy. Their core mission is to address critical clinical problems faced by thousands of newborns daily. Prapela offers a reusable pad that can be placed inside hospital bassinets or incubators to provide gentle, stochastic stimulation, enhancing natural breathing control and oxygenation processes. The company's primary market focus is on hospitals and neonatal care units.
Notable affiliated individuals include experts in pediatric healthcare and medical device innovation. Prapela has garnered significant recognition, becoming America's most-awarded pediatric medical device startup. The company has secured over $8 million in grants, underscoring its impact and potential in neonatal care. Their innovative approach has provided caregivers and parents with a reliable solution to improve newborn health outcomes, solidifying Prapela's position as a leader in pediatric medical devices.